How Is IDEXX Laboratories’ Stock Performance Compared to Other Health Care Stocks?

Core Viewpoint - IDEXX Laboratories, Inc. is a global leader in veterinary diagnostics and animal-health technology, with a strong market position supported by a diversified product ecosystem and a high-margin, recurring-revenue model [1][2][3] Company Overview - IDEXX Laboratories, Inc. is headquartered in Westbrook, Maine, and operates in over 170 countries, providing diagnostic instruments, rapid tests, laboratory services, and software primarily for companion animals [1] - The company is classified as a large-cap stock, with a market capitalization of over $10 billion, reflecting its significant presence in the veterinary diagnostics market [2] Financial Performance - Shares of IDEXX have decreased 5.7% from their 52-week high of $769.98, but have increased 14.5% over the past three months, outperforming the Health Care Select Sector SPDR Fund's (XLV) 3.3% return [4] - Over the past 52 weeks, IDEXX stock has rallied 68%, significantly outpacing XLV's 10.6% decline, and is up 75.6% year-to-date compared to XLV's marginal return [5] - Following the Q3 results, IDEXX shares climbed 14.8%, with an EPS of $3.40 exceeding estimates and revenue of $1.11 billion surpassing expectations, driven by growth in the Companion Animal Group diagnostics segment [6]